UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Capivasertib restricts sars-cov-2 cellular entry: A potential clinical application for covid-19 Journal article
Fang Sun, Chenglin Mu, Hang Fai Kwok, Jiyuan Xu, Yingliang Wu, Wanhong Liu, Jean-Marc Sabatier, Cédric Annweiler, Xugang Li, Zhijian Cao, Yingqiu Xie. Capivasertib restricts sars-cov-2 cellular entry: A potential clinical application for covid-19[J]. International Journal of Biological Sciences, 2021, 17(9), 2348-2355.
Authors:  Fang Sun;  Chenglin Mu;  Hang Fai Kwok;  Jiyuan Xu;  Yingliang Wu; et al.
Favorite | TC[WOS]:33 TC[Scopus]:31  IF:8.2/8.3 | Submit date:2022/05/13
Akt Inhibitor  Antiviral Activity  Capivasertib  Covid-19  Sars-cov-2